Clinical and biological characteristics of the patients
Characteristic . | No. (total) . | % . | Range . |
---|---|---|---|
Sex | |||
Male | 4 | ||
Female | 11 | ||
Age at diagnosis, y | 44 | 29-57 | |
Tobacco use | 100 | ||
Lymphocyte count ×109/L | 6 | 3.2-14.5 | |
Lymphocyte count, % of leukocytes | 49 | 30-77 | |
Binucleated lymphocytes | 5 | 2-11 | |
Splenomegaly | 3/13 | 23 | |
Increased polyclonal immunoglobulin M | 10/10 | 100 | |
HLA-DR7 | 7/12 | 58 | |
Cytogenetic abnormalities | 10/15 | 67 | |
+I3q | 8/15 | 53 | |
Lymphoma evolution | 1/15 | 6.7 |
Characteristic . | No. (total) . | % . | Range . |
---|---|---|---|
Sex | |||
Male | 4 | ||
Female | 11 | ||
Age at diagnosis, y | 44 | 29-57 | |
Tobacco use | 100 | ||
Lymphocyte count ×109/L | 6 | 3.2-14.5 | |
Lymphocyte count, % of leukocytes | 49 | 30-77 | |
Binucleated lymphocytes | 5 | 2-11 | |
Splenomegaly | 3/13 | 23 | |
Increased polyclonal immunoglobulin M | 10/10 | 100 | |
HLA-DR7 | 7/12 | 58 | |
Cytogenetic abnormalities | 10/15 | 67 | |
+I3q | 8/15 | 53 | |
Lymphoma evolution | 1/15 | 6.7 |